Casdin Capital LLC Invests $11.01 Million in Cigna Group $CI

Casdin Capital LLC acquired a new position in shares of Cigna Group (NYSE:CI) in the 4th quarter, Holdings Channel reports. The fund acquired 40,000 shares of the health services provider’s stock, valued at approximately $11,009,000. Cigna Group makes up about 0.7% of Casdin Capital LLC’s portfolio, making the stock its 24th biggest holding.

Other institutional investors have also modified their holdings of the company. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $25,000. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $28,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $29,000. Prosperity Bancshares Inc purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $29,000. Finally, Lodestone Wealth Management LLC purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $32,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

Shares of CI opened at $285.27 on Thursday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The stock has a market capitalization of $75.46 billion, a P/E ratio of 12.09, a P/E/G ratio of 1.13 and a beta of 0.28. The company’s fifty day moving average is $283.63 and its two-hundred day moving average is $278.31.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the prior year, the company posted $6.74 EPS. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Analyst Ratings Changes

Several analysts have recently weighed in on CI shares. Mizuho boosted their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a report on Friday, May 1st. Piper Sandler cut their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Finally, Wolfe Research reissued an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $338.30.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.